Federated Hermes’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Federated Hermes's BIIB Position: Q2 2026 in Review
Federated Hermes increased its Biogen (BIIB) stake by 1.1% in Q2 2026, buying an estimated $198K and bringing the position to 98,315 shares worth $21.2M. The position accounts for 0.03% of the portfolio, ranked #482.
Federated Hermes first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $187M in Q1 2015. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Federated Hermes held 98,315 shares of Biogen worth $21.2M as of Q2 2026.
- Federated Hermes bought 1,036 Biogen shares in Q2 2026, an estimated $198K.
- Biogen made up 0.03% of Federated Hermes's portfolio in Q2 2026, its #482 holding.
- Federated Hermes first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Federated Hermes's Biogen position peaked at $187M in Q1 2015.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.